| 注册
首页|期刊导航|物理化学学报|基于枸杞衍生碳点构建pH响应性纳米疫苗用于增强肿瘤免疫治疗

基于枸杞衍生碳点构建pH响应性纳米疫苗用于增强肿瘤免疫治疗

徐庆文 谢志刚 郑敏

物理化学学报2026,Vol.42Issue(6):72-84,13.
物理化学学报2026,Vol.42Issue(6):72-84,13.DOI:10.1016/j.actphy.2025.100203

基于枸杞衍生碳点构建pH响应性纳米疫苗用于增强肿瘤免疫治疗

Construction of pH-responsive Lycium barbarum-derived carbon dots nanovaccines for enhanced anti-tumor immunotherapy

徐庆文 1谢志刚 2郑敏1

作者信息

  • 1. 长春工业大学化学与生命科学学院,材料科学高等研究院,吉林 长春 130012
  • 2. 中国科学院长春应用化学研究所,高分子生态材料重点实验室,吉林 长春 130022
  • 折叠

摘要

Abstract

Immunotherapy has become a key focus in cancer treatment,and cancer nanovaccines have made significant progress as a representative approach in this field.However,some issues such as low immunogenicity,inefficient antigen delivery,and poor immune responses have limited the advancement of immunotherapy.To address these limitations,this study developed a pH-responsive nanovaccine(Lyc-OVA)based on Lycium barbarum-derived carbon dots(Lyc-CDs)synthesized via a green hydrothermal method.Owing to retained Lycium barbarum polysaccharides(LBP,18.43%total sugar content),Lyc-CDs demonstrated superior loading efficiency(48.40%)and pH-responsive release(80%OVA released within 24 h at pH 5.4)of OVA.Molecular docking simulations identified hydrogen bonding and π-cation interactions between LBP monosaccharides(rhamnose/galactose)and OVA.Lyc-OVA promoted dendritic cell maturation(32.87%CD80+CD86+cells,comparable to LPS)and cytokine secretion(TNF-α:13.10 pg mL-1;IFN-γ:17.78 pg mL-1;IL-6:3.74 pg mL-1).In a bilateral B16-OVA melanoma model,Lyc-OVA suppressed primary/distal tumor growth(80.36%/82.16%inhibition rates)by activating CD4+CD8+T cells,reducing immunosuppressive Treg/MDSC populations,and reshaping the tumor immune microenvironment.This work highlights the multifunctional role of natural polysaccharides in nanovaccine and provides an effective strategy for tumor immunotherapy.

关键词

枸杞/碳点/纳米疫苗/肿瘤微环境/肿瘤免疫治疗

Key words

Lycium barbarum/Carbon dots/Nanovaccines/Tumor microenvironment/Tumor immunotherapy

分类

化学化工

引用本文复制引用

徐庆文,谢志刚,郑敏..基于枸杞衍生碳点构建pH响应性纳米疫苗用于增强肿瘤免疫治疗[J].物理化学学报,2026,42(6):72-84,13.

基金项目

本研究得到了国家自然科学基金项目(51873023)、国家重点研发计划项目(2024YFA1210304)及吉林省教育厅科学技术研究项目(JJKH20250699KJ)资助 (51873023)

物理化学学报

1000-6818

访问量0
|
下载量0
段落导航相关论文